🇺🇸 Ciprofloxacin Ophthalmic in United States

Ciprofloxacin Ophthalmic (Ciprofloxacin Ophthalmic) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Ciprofloxacin Ophthalmic in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Ciprofloxacin Ophthalmic approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Ciprofloxacin Ophthalmic in United States?

Medical University of Vienna is the originator. The local marketing authorisation holder may differ — check the official source linked above.